[{"indications": "Indications\u00a0\n(From Topiramate: British National Formulary)\nTopiramate", "name": "TOPIRAMATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.8 Antiepileptic drugs", "4.8.1 Control of the epilepsies", "Topiramate", "TOPIRAMATE"], "cautions": "Cautions\u00a0avoid abrupt withdrawal; risk of metabolic acidosis; risk of nephrolithiasis\u2014ensure adequate hydration (especially\r\nin strenuous activity or warm environment); avoid in acute\r\nporphyria (section 9.8.2); interactions: see Interactions in section 4.8.1 and Appendix 1 (topiramate)Important\u00a0Topiramate has been associated\r\nwith acute myopia with secondary angle-closure glaucoma, typically\r\noccurring within 1 month of starting treatment. Choroidal effusions resulting in anterior displacement of the lens\r\nand iris have also been reported. If raised intra-ocular pressure occurs:seek specialist ophthalmological advice;use appropriate measures to reduce intra-ocular pressure;stop topiramate as rapidly as feasible", "side-effects": "Side-effects\u00a0nausea, diarrhoea, vomiting, constipation, dyspepsia,\r\nabdominal pain, dry mouth, taste disturbance, gastritis, appetite\r\nchanges, dyspnoea, impaired attention, cognitive impairment, movement\r\ndisorders, seizures, tremor, malaise, impaired coordination, speech\r\ndisorder, drowsiness, dizziness, sleep disturbance, anxiety, confusion,\r\nparaesthesia, aggression, mood changes, depression, agitation, irritability,\r\nnephrolithiasis, urinary disorders, anaemia, arthralgia, muscle spasm,\r\nmyalgia, muscular weakness, visual disturbances, nystagmus, tinnitus,\r\nepistaxis, alopecia, rash, pruritus; less commonly pancreatitis, flatulence, abdominal distension, gingival bleeding,\r\nsalivation, halitosis, thirst, glossodynia, bradycardia, palpitation,\r\nhypotension, postural hypotension, flushing, altered sense of smell,\r\nperipheral neuropathy, suicidal ideation, psychosis, panic attack,\r\ninfluenza-like symptoms, sexual dysfunction, urinary calculus, haematuria,\r\nblood disorders (including leucopenia, neutropenia, and thrombocytopenia),\r\nhypokalaemia, metabolic acidosis, dry eye, photophobia, blepharospasm,\r\nincreased lacrimation, mydriasis, hearing loss, reduced sweating,\r\nskin discoloration; rarely Raynaud\u2019s syndrome, periorbital\r\noedema, unilateral blindness, Stevens-Johnson syndrome, abnormal skin\r\nodour, calcinosis; very rarely angle-closure glaucoma; also reported encephalopathy, hyperammonaemia, maculopathy,\r\ntoxic epidermal necrolysis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/213574.htm", "doses": ["Monotherapy in epilepsy, initially 25\u00a0mg at night for\r\n1 week then increased in steps of 25\u201350\u00a0mg taken\r\nin 2 divided doses at intervals of 1\u20132 weeks; usual dose 100\u2013200\u00a0mg\r\ndaily in 2 divided doses, adjusted according to response; max. 500\u00a0mg\r\ndaily (doses of 1\u00a0g daily have been used in refractory epilepsy); child 6\u201318 years, initially 0.5\u20131\u00a0mg/kg (max. 25\u00a0mg)\r\nat night for 1 week then increased in steps of 0.5\u20131\u00a0mg/kg\r\n(max. 50\u00a0mg) taken in 2 divided doses at intervals of 1\u20132 weeks; initial\r\ntarget dose 100\u00a0mg daily in 2 divided doses; max. 15\u00a0mg/kg (max. 500\u00a0mg)\r\ndaily", "Adjunctive therapy in epilepsy, initially 25\u201350\u00a0mg at night\r\nfor 1 week then increased in steps of 25\u201350\u00a0mg taken\r\nin 2 divided doses at intervals of 1\u20132 weeks; usual dose 200\u2013400\u00a0mg\r\ndaily in 2 divided doses; max. 400\u00a0mg daily; child 2\u201318 years, initially 1\u20133\u00a0mg/kg (max. 25\u00a0mg) at night for 1 week then increased in steps of 1\u20133\u00a0mg/kg (max. 50\u00a0mg) taken\r\nin 2 divided doses at intervals of 1\u20132 weeks; usual dose 5\u20139\u00a0mg/kg\r\ndaily in 2 divided doses; max. 15\u00a0mg/kg (max. 400\u00a0mg) daily", "Migraine prophylaxis, adult over\r\n18 years, initially 25\u00a0mg at night for 1 week then increased in steps of 25\u00a0mg at weekly intervals; usual dose 50\u2013100\u00a0mg\r\ndaily in 2 divided doses; max. 200\u00a0mg daily; child 16\u201318 years see BNF for Children"], "pregnancy": "Pregnancy\u00a0see Pregnancy"}]